{
    "organizations": [],
    "uuid": "46d414f475cb2dfa856fd343e3cfbbffef742dbb",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sunesis-pharmaceuticals-qtrly-loss/brief-sunesis-pharmaceuticals-qtrly-loss-per-share-0-21-idUSASC0A0KP",
    "ord_in_thread": 0,
    "title": "BRIEF-Sunesis Pharmaceuticals Qtrly Loss Per Share $0.21",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 8 (Reuters) - Sunesis Pharmaceuticals Inc:\n* SUNESIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS\n* Q1 REVENUE $200,000 VERSUS I/B/E/S VIEW $200,000 * QTRLY LOSS PER SHARE $0.21 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T06:46:00.000+03:00",
    "crawled": "2018-05-09T12:44:26.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "sunesis",
        "pharmaceutical",
        "inc",
        "sunesis",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "recent",
        "highlight",
        "q1",
        "revenue",
        "versus",
        "view",
        "qtrly",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}